Erasca Inc (NASDAQ: ERAS) – Not A Clear Buying Opportunity?
Erasca Inc (ERAS) concluded trading on Thursday at a closing price of $2.45, with 3.75 million shares of worth about $9.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.11% during that period and on December 19, 2024 the price saw a loss […]
Erasca Inc (NASDAQ: ERAS) – Not A Clear Buying Opportunity?
Erasca Inc (ERAS) concluded trading on Wednesday at a closing price of $2.52, with 3.28 million shares of worth about $8.27 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.13% during that period and on October 02, 2024 the price saw a loss […]
Now Is A Suitable Moment For A Long-Term Purchase Of Erasca Inc (NASDAQ: ERAS)
Armistice Capital LLC recently announced the acquisition of new stake in Erasca Inc (NASDAQ:ERAS). The institutional investor has increased its shareholding in the Healthcare company by 6.36% to 8.36 million shares with purchase of 0.5 million shares. This fresh investment now brings its stake to 5.53% valued currently at $17.8 million. In addition, BlackRock Fund […]
